MOTION-BASED DRUG DESIGN
Live / Registered — Registered (as of 13 Sept 2022)
What this means for you
Registered since 13 Sept 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88915491
- Registration number
- 6847234
- Mark type
- Stylized text
- Filed
- 14 May 2020
- Published for opposition
- 30 Mar 2021
- Registered
- 13 Sept 2022
- Attorney of record
- Jennifer Insley-Pruitt
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical drug discovery services; pharmaceutical and biotechnology research and development services; medical and scientific research services; design and development of pharmaceutical preparations and medicines; research and development in the field of drug discovery
Owner
- Relay Therapeutics, Inc., Cambridge, MA, US
- Relay Therapeutics, Inc., Cambridge, MA, US
- Relay Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 04 Feb 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 04 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 04 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 04 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 13 Sept 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 Sept 2022 — REGISTERED-PRINCIPAL REGISTER
- 11 Aug 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Aug 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Jun 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Jun 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 25 May 2022 — USE AMENDMENT FILED
- 15 Jun 2022 — SOU EXTENSION 3 GRANTED
- 25 May 2022 — SOU EXTENSION 3 FILED
- 13 Jun 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 25 May 2022 — TEAS STATEMENT OF USE RECEIVED